CHAMPIONS ONCOLOGY INC (CSBR:NASDAQ)
$5.53 -0.53 (-8.7459%)
Analysed CHAMPIONS ONCOLOGY INC (CSBR:NASDAQ) News Sources
Champions Oncology (CSBR) Earnings Transcript
13-03-2026
fool.com
Champions Oncology Inc (CSBR) Q3 2026 Earnings Call Highlights: Record Services Revenue and ...
19-03-2026
yahoo.com
Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy
30-03-2026
yahoo.com
Champions Oncology to Present New Data on Predicting Response and Resistance at AACR 2026
09-04-2026
yahoo.com
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 27, 2026
20-07-2026
yahoo.com
Zacks Initiates Coverage of Champions Oncology With Neutral Recommendation
22-07-2026
yahoo.com
2 Microcaps With Gross Margin Catalysts
23-07-2026
yahoo.com
CSBR vs. CTKB: Which Life Sciences Stock Has Better Long-Term Upside?
23-07-2026
yahoo.com
Champions Oncology Reports Record Annual Revenue of $59 Million
27-07-2026
yahoo.com
Champions Oncology Q4 Earnings Call Highlights
27-07-2026
marketbeat.com
What is the current price of CHAMPIONS ONCOLOGY INC (CSBR:NASDAQ)?
The current price of CHAMPIONS ONCOLOGY INC (CSBR:NASDAQ) is $5.53.
CHAMPIONS ONCOLOGY INC (CSBR:NASDAQ) absolute price change since previous trading day?
The absolute price change of CHAMPIONS ONCOLOGY INC (CSBR:NASDAQ) since the previous trading day is $-0.53.
CHAMPIONS ONCOLOGY INC (CSBR:NASDAQ) percentage price change since previous trading day?
The percentage price change of CHAMPIONS ONCOLOGY INC (CSBR:NASDAQ) since the previous trading day is -8.7459%.
What is the most recent average sentiment score for CHAMPIONS ONCOLOGY INC (CSBR:NASDAQ)?
The most recent average sentiment score for CHAMPIONS ONCOLOGY INC (CSBR:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for CHAMPIONS ONCOLOGY INC (CSBR:NASDAQ)?
The most recent sentiment for CHAMPIONS ONCOLOGY INC (CSBR:NASDAQ) is .
SEC-8K** Filing Available For CHAMPIONS ONCOLOGY INC (CSBR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.